Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Mesothelioma 2Mesothelioma, Malignant 1

Interventions

Pemetrexed 5Carboplatin 5pembrolizumab 4Nivolumab 4Cisplatin 4fludarabine 3Ipilimumab 3Cyclophosphamide 3Radiotherapy, Intensity-Modulated 2Cerebral Decortication 2sotorasib 1ruxolitinib 1osimertinib 1olaparib 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1avelumab 1atezolizumab 1Platinum 1LY2940680 1Influenza Vaccines 1Gemcitabine 1Fluorodeoxyglucose F18 1Blood Component Removal 1Bevacizumab 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma × Cerebral Decortication × 90 days × Clear all
NCT04158141 2026-05-19

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

NRG Oncology

Phase 3 Terminated
16 enrolled 18 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00715611 2026-05-14

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
65 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡